Ethanol Consumption by Lactating Rats Induces Changes in Pup's Fatty Acid Profiles

Trans fatty acids from milk of Brazilian mothers of premature infants

AIM

The presence of trans fatty acids (TFA) in human milk may be a concern because of their possible adverse nutritional effects on the infant development. TFA may interfere with the metabolism of long-chain polyunsaturated fatty acids (LC-PUFA). Marked variation in TFA of milk appears in different populations. No data have yet been reported in Brazil, particularly as regards the milk of mothers of premature infants. Because of the importance of LC-PUFA in infant growth and development, we investigated the fatty acids composition of the milk of Brazilian mothers of premature infants.

METHODS

We analysed, through gas-liquid chromatography, the content of fatty acids of 37 milk samples obtained from mothers delivering prematurely. Samples were collected from colostrum and mature milk of exclusive breastfeeding.

RESULTS

All samples contained trans isomers of C18:1 acid with trans isomers of PUFA in lower proportion. The percentage of TFA (mean +/- SD) in the colostrum was 2.34 +/- 0.75, and 2.19 +/- 0.47 in the mature milk. For the LC-PUFA these values were 0.97 +/- 0.34 in the colostrum and 0.66 +/- 0.25 in the mature milk. The contents of total essential fatty acids and PUFA n-6 were inversely correlated with TFA in colostrum and mature milk. We found a positive correlation between levels of arachidonic acid in mature milk and change in the children's height.

CONCLUSIONS

The study showed that the intake of TFA occupies an intermediate position between the values of North America and European countries, reflecting the ongoing transition to industrialised foods in Brazil.

Safety assessment of myristic acid as a food ingredient

Myristic acid is used in the food industry as a flavor ingredient. It is found widely distributed in fats throughout the plant and animal kingdom, including common human foodstuffs, such as nutmeg. Myristic acid (a 14-carbon, straight-chain saturated fatty acid) has been shown to have a low order of acute oral toxicity in rodents. It may be irritating in pure form to skin and eyes under exaggerated exposure conditions, but is not known or predicted to induce sensitization responses. Myristic acid did not induce a mutagenic response in either bacterial or mammalian systems in vitro. Relevant subchronic toxicity data are available on closely related fatty acid analogs. In particular, a NOEL of >6000mg/kg was reported for lauric acid (a 12-carbon, straight-chain saturated fatty acid) following dietary exposure to male rats for 18 weeks and a NOEL of >5000mg/kg was reported for palmitic acid (a 16-carbon, straight-chain saturated fatty acid) following dietary exposure to rats for 150 days. The data and information that are available indicate that at the current level of intake, food flavoring use of myristic acid does not pose a health risk to humans.

Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria

The recent literature on polyunsaturated fatty acid metabolism in phenylketonuria (PKU) is critically analyzed. The data suggest that developmental impairment of the accretion of brain arachidonic (20:4n-6) and docosahexaenoic (22:6n-3, DHA) acids is a major etiological factor in the microcephaly and mental retardation of uncontrolled PKU and maternal PKU. These fatty acids appear to be synthesized by the recently elucidated carnitine-dependent, channeled, mitochondrial fatty acid desaturases for which alpha-tocopherolquinone (alpha-TQ) is an essential enzyme cofactor. alpha-TQ can be synthesized either de novo or from alpha-tocopherol. The fetus and newborn would primarily rely on de novo alpha-TQ synthesis for these mitochondrial desaturases because of low maternal transfer of alpha-tocopherol. Homogentisate, a pivotal intermediate in the de novo pathway of alpha-TQ synthesis, is synthesized by 4-hydroxyphenylpyruvate dioxygenase. The major catabolic products of excess phenylalanine, viz. phenylpyruvate and phenyllactate, are proposed to inhibit alpha-TQ synthesis at the level of the dioxygenase reaction by competing with its 4-hydroxyphenylpyruvate substrate, thus leading to a developmental impairment of 20:4n-6 and 22:6n-3 synthesis in uncontrolled PKU and fetuses of PKU mothers. The data suggest that dietary supplementation with carnitine, 20:4n-6, and 22:6n-3 may have therapeutic value for PKU mothers and for PKU patients who have been shown to have a low plasma status of these essential metabolites.